MedicalFX Group (08161) will no longer publish quarterly results and quarterly reports
MedicalExchange Group (08161) issued an announcement according to the Hong Kong Stock Exchange Limited which took effect on January 1, 2024...
Yihui Group (08161) announced interim results, losses attributable to shareholders of HK$2.27 million
Medical Exchange Group (08161) announced the results for the six months ended September 30, 2023, with a profit of 58.083 million...
MEDINET GROUP: INTERIM REPORT 2023
MEDINET GROUP: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
MEDINET GROUP: First Quarterly Report 2023
Medical Exchange Group (08161) Releases First Quarter Results Shareholders' Payable Loss of HK$960,000 Year-Over-Year Profit and Loss
According to the Zhitong Finance App, Medical Exchange Group (08161) announced the first quarter results for the three months ended June 30, 2023. The group achieved earnings of HK$29.127 million during the period, an increase of 2.61% over the previous year; shareholders should account for a loss of HK$960,000; shareholders should account for HK$105,000 in profit for the same period last year, with profit to loss of HK$105,000 over the previous year; a basic loss of HK$2.3 cents per share. According to the announcement, revenue from medical treatment programs provided to contract clients increased from about HK$6.5 million in the three months ending June 30, 2022 to about HK$10.2 million during this period, an increase of about 57.8%, mainly due to patients' visits to the Union
MEDINET GROUP: FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 30 JUNE 2023
MEDINET GROUP: ANNUAL REPORT 2023
Medical Exchange Group (08161.HK) increased its annual net loss to HK$24.9 million
On June 27, 丨Medical Exchange Group (08161.HK) announced that for the year ended March 31, 2023, the company and its subsidiaries earned about HK$110.4 million, a decrease of about HK$10.7 million or 8.8% from the year ended March 31, 2022. Company owners' losses for the year increased from approximately HK$6.2 million for the year ended March 31, 2022 to approximately HK$24.9 million for the year ended March 31, 2023.
MEDINET GROUP: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2023
Medicare Group (08161) issued a profit warning. The estimated annual loss after tax is not less than HK$24 million
According to the Zhitong Finance App, Medicare Group (08161) announced that it is expected that the Group will achieve a loss of no less than HK$24 million after tax for the year ending March 31, 2023, while the year ending March 31, 2022 will have a loss of approximately HK$6 million after tax. The Group's anticipated increase in losses is mainly due to: the loss of goodwill impairment of approximately HK$17 million from the company's subsidiary Heng Quan Limited (Heng Quan, which provides dental services) was confirmed to generate cash; and the continued COVID-19 outbreak had an adverse impact on the number of patient visits, leading to 31 March 2023
MEDINET GROUP: PROFIT WARNING
MEDINET GROUP: NOTICE OF BOARD MEETING
Medicare Group: Performance Report for the Third Quarter of 2022
Medicare Group (08161.HK) lost approximately HK$5.1 million in the first three quarters
Gelonghui, Feb. 10 | MedicineExchange Group (08161.HK) announced that the company's revenue for the nine months ending December 31, 2022 was approximately HK$83.5 million, a year-on-year decrease of about HK$14.6 million. The net loss attributable to company owners during the period was approximately HK$5.1 million (December 31, 2021: net loss of approximately HK$1.6 million). The Board is not recommending an interim dividend for the nine months ending 31 December 2022.
MedicineExchange Group: Third Quarterly Results Announcement for the Nine Months Ended December 31, 2022
Medinet Co 1Q Parent Loss Y325.00M Vs Loss Y342.00M
Medinet Co. Ltd. (2370.TO) Japan 1st Quarter Ended December 31 PARENT 2022 2021 Revenue Y185.00 mln Y172.00 mln Operating Profit
MedicineExchange Group: Profit Warning
Medical Huihui Group: interim report 2022
Medicare Group (08161.HK)'s interim profit and loss reached HK$45,000
Gelonghui, November 14, 丨 MedicineExchange Group (08161.HK) announced that for the six months ending September 30, 2022, the company's revenue was HK$587.23 million, a year-on-year decrease of 11.45%; the loss attributable to the company's shareholders during the period was HK$45,000, compared with a profit of HK$225,000 for the same period last year; the basic loss per share was HK$0.107 cents.
No Data